Published in Magnesium on January 01, 1986
The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone. J Clin Invest (1971) 4.32
Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum (1999) 1.58
Neurologic disturbances in Paget disease of bone: response to calcitonin. Neurology (1979) 1.48
Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment. Am J Med (1974) 1.44
Absolute and relative deficit in total-skeletal calcium and radial bone mineral in osteoporosis. J Nucl Med (1974) 1.35
Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res (1987) 1.31
Prolonged estrogen therapy in postmenopausal women. J Am Med Assoc (1959) 1.30
Hypercalcemia in mycobacterial infection. J Clin Endocrinol Metab (1972) 1.22
Hypoparathyroidism. Clinical observations in 34 patients. Arch Intern Med (1967) 1.11
The cellular transport of calcium in rat liver. J Gen Physiol (1966) 1.11
The bone "quality" problem. Calcif Tissue Int (1992) 0.98
Plasma calcitonin in pycnodysostosis: intermittently high basal levels and exaggerated responses to calcium and glucagon infusions. J Clin Endocrinol Metab (1973) 0.97
Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment. J Clin Endocrinol Metab (1976) 0.97
Thyroidal content of thyrocalcitonin in hypothyroid and hyperthyroid rats. Endocrinology (1967) 0.93
Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D. Endocrinology (1967) 0.92
The effect of parathyroid hormone on hepatic cell transport of calcium. Endocrinology (1972) 0.90
Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone. Metabolism (1974) 0.86
Effects of porcine calcitonin in osteogenesis imperfecta tarda. J Pediatr (1972) 0.85
Skeletal turnover and total body elemental composition during extended calcitonin treatment of Paget's disease. Metabolism (1975) 0.84
Tissue distribution and transport of electrolytes Mg28 and Ca47 in hypermagnesemia. Metabolism (1967) 0.84
Tissue distribution of electrolytes, 47ca and 28mg in experimental hyper- and hypoparathyroidism. Endocrinology (1966) 0.83
In vivo inhibition of bone resorption by thyrocalcitonin. Endocrinology (1967) 0.83
An immune hemagglutination procedure with very high sensitivity applied to the detection of hepatitis B antibody and antigen and immune complex. Vox Sang (1975) 0.83
Effects of growth hormone in osteoporosis. J Clin Endocrinol Metab (1976) 0.83
Treatment of osteoporosis with calcitonin. Semin Drug Treat (1972) 0.82
Placental transport of chromium. J Am Coll Nutr (1984) 0.82
Effect of vitamin D on tissue distribution and transport of electrolytes, 47-Ca and 28-Mg. Endocrinology (1966) 0.81
In vivo neutron activation analysis. Clinical potential in body composition studies. Am J Med (1974) 0.81
Clinical and biochemical aspects of chromium deficiency. J Am Coll Nutr (1985) 0.81
Magnesium transport in patients with thyroid disease. J Clin Endocrinol Metab (1966) 0.81
Hormonal effects of calcium transport in liver. Clin Orthop Relat Res (1971) 0.80
Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis. J Bone Miner Res (1986) 0.80
Treatment of Paget's disease of bone with once a week injections of salmon calcitonin. Br Med J (1975) 0.80
Primary hyperparathyroidism and breast cancer. Am J Med (1976) 0.80
Zinc deficiency in a patient with retarded growth, hypogonadism, hypogammaglobulinemia and chronic infection. Am J Med Sci (1969) 0.80
Interactions of estradiol and calcitonin on the rat skeleton. Endocrinology (1973) 0.79
Effects of rigid fixation device composition on three-dimensional computed axial tomography imaging: direct measurements on a pig model. J Oral Maxillofac Surg (1994) 0.78
Interactions of thyroxine and thyrocalcitonin in the rat. Endocrinology (1970) 0.78
Magnesium transport in humans with hypomagnesemia. J Clin Endocrinol Metab (1969) 0.78
Treatment of Paget's disease. Adv Intern Med (1982) 0.78
The cellular transport of magnesium in rat liver. J Gen Physiol (1970) 0.77
Etoposide admixed with cisplatin. Phase I clinical investigation of 72-hour infusion. Cancer (1989) 0.77
Thyroxine-induced stimulation of hepatic cell transport of calcium and magnesium. J Clin Invest (1972) 0.77
Effects of synthetic salmon calcitonin in osteogenesis imperfecta. Curr Ther Res Clin Exp (1974) 0.77
Magnesium transport in normal and uremic patients. J Clin Endocrinol Metab (1966) 0.77
Management of osteoporosis. Hosp Pract (1978) 0.76
Osteoporosis: the need for comprehensive treatment guidelines. Clin Ther (1997) 0.76
A trial of calcitonin therapy in renal osteodystrophy. Nephron (1973) 0.76
Cytokines and bone metabolism. Calcif Tissue Int (1993) 0.76
Studies of thyrocalcitonin action. Endocrinology (1966) 0.76
A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation. Cancer (1989) 0.75
Radiochromium distribution in thyroid and parathyroid deficiency. Am J Clin Nutr (1980) 0.75
Idiopathic periostitis with hypercalcemia. Am J Med (1967) 0.75
Effect of insulin on radiochromium distribution in diabetic rats. Endocrinology (1979) 0.75
Magnesium deficiency and neurologic deficits. Am J Med (1994) 0.75
Cyclophosphamide, methotrexate, and 5-fluorouracil in a three-drug admixture. Phase I trial of 14-day continuous ambulatory infusion. Cancer (1989) 0.75
Credentials available in human clinical nutrition: a report of the Intersociety Committee on Nutrition Certification. J Am Coll Nutr (1997) 0.75
Automated analysis of hydroxyproline with elimination of non-specific reacting substances. Clin Chim Acta (1979) 0.75
Radiochromium conservation and distribution in diuretic states. J Am Coll Nutr (1983) 0.75
Quantitation of the degree of osteoporosis by measure of total-body calcium employing neutron activation. Calcif Tissue Res (1976) 0.75
Tissue chromium exchange in the rat. Am J Clin Nutr (1981) 0.75
Primary hypophosphatemic rickets in an elderly woman. Arch Intern Med (1973) 0.75
Three adult cases resembling hereditary bone dysplasia. Metab Bone Dis Relat Res (1981) 0.75
Optic neuropathy in Paget's disease. Am J Ophthalmol (1984) 0.75
Treatment of Paget's disease with calcitonin. Semin Drug Treat (1972) 0.75
Physical and biochemical factors in bone metabolism. Calcif Tissue Int (1992) 0.75
Chronic joint pain. Arthritis or osteitis? Hosp Pract (Off Ed) (1985) 0.75
Tissue magnesium content in diabetic rats. Magnesium (1987) 0.75
Radiochromium distribution during saline diuresis. J Am Coll Nutr (1986) 0.75
Bone collagenase in assessment of the clinical course of metabolic bone disease. Surg Forum (1971) 0.75
Effects of furosemide on biliary secretion, pancreatic blood flow, and pancreatic exocrine secretion. J Clin Pharmacol (1983) 0.75
Effect of thyrocalcitonin on calcium exchange in rat tissues. Endocrinology (1965) 0.75
Credentials available in human clinical nutrition: a report of the Intersociety Committee on Nutrition Certification. Am J Clin Nutr (1997) 0.75
Combined floxuridine and cisplatin in a fourteen day infusion. Phase I study. Cancer (1988) 0.75
Furosemide vasodilates the canine gastrointestinal tract. J Clin Pharmacol (1982) 0.75
Factors in bone formation. Calcif Tissue Int (1989) 0.75
Paget's disease: New treatment for an old disease. Am Fam Physician (1976) 0.75
Pancreatic exocrine function and cyclic nucleotides in the diabetic rat. J Am Coll Nutr (1984) 0.75
Adult hypophosphatasia in a geriatric patient. J Am Geriatr Soc (1988) 0.75
Radiochromium distribution in aged rats. J Am Coll Nutr (1986) 0.75
Hormonal factors in osteoporosis. Clin Orthop Relat Res (1979) 0.75
Primary renal tubular acidosis and secondary hyperparathyroidism. Am J Med (1972) 0.75
Discussion: Newer bisphosphonates in the treatment of Paget's disease of bone: where we are and where we want to go. J Bone Miner Res (1999) 0.75
Diagnosis of hyperparathyroidism. Minn Med (1965) 0.75
Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. A phase I study. Cancer (1989) 0.75
Long-term treatment of osteogenesis imperfecta tarda in adults with salmon calcitonin and calcium. Curr Ther Res Clin Exp (1976) 0.75
Effect of LH and FSH on vanadium distribution in hypophysectomized rats. Proc Soc Exp Biol Med (1980) 0.75
Radiomagnesium turnover studies in hypomagnesemic states. Ann N Y Acad Sci (1969) 0.75
Radiochromium distribution in hypophysectomized and adrenalectomized rats. Endocrinology (1979) 0.75
Effect of phosphate and magnesium infusions on skeletal turnover and renal content of calcium, phosphorus and magnesium in rats. Endocrinology (1973) 0.75
Determination of whole body magnesium by in vivo neutron activation. Int J Nucl Med Biol (1973) 0.75